Emmaus Life Sciences, Inc. Common Stock
EMMA
EMMA was delisted on the 10th of September, 2019.
11 hedge funds and large institutions have $95K invested in Emmaus Life Sciences, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
22% more funds holding
Funds holding: 9 → 11 (+2)
35% less capital invested
Capital invested by funds: $147K → $95K (-$52K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$90.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$12.1K |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$5.06K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$72K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$377 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $49K | +$90.2K | +11,237 | New |
|
|
CC
2
Cannell & Co
New York
| $15K | – | – | – |
|
|
FFA
3
First Foundation Advisors
Irvine,
California
| $12K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $9K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $7K | +$12.1K | +1,501 | New |
|
|
6
Macquarie Group
Sydney, NSW 2000,
Australia
| $3K | +$5.06K | +630 | New |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$72K | -7,584 | Closed |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | -$377 | -47 | -98% |
|
EMMA Hedge Fund Activity: Q4 2018 in Review
11 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Emmaus Life Sciences, Inc. Common Stock (EMMA) for Q4 2018, worth a combined $95K — down 35% from $147K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new EMMA positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $90.2K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $72K sold.
- 11 institutional investors held Emmaus Life Sciences, Inc. Common Stock (EMMA) as of Q4 2018, up from 9 in Q3 2018.
- Funds reported $95K of Emmaus Life Sciences, Inc. Common Stock stock for Q4 2018, down 35% quarter-over-quarter.
- 3 funds opened new Emmaus Life Sciences, Inc. Common Stock positions in Q4 2018 and 1 closed out, a net change of +2 holders.
- The largest Emmaus Life Sciences, Inc. Common Stock buyer in Q4 2018 was Citadel Advisors, an estimated $90.2K added.
- The largest Emmaus Life Sciences, Inc. Common Stock seller in Q4 2018 was Susquehanna International Group, an estimated $72K sold.
Based on aggregated 13F filings for Q4 2018.